Cargando…

Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial

BACKGROUND: Intensive care unit (ICU) physicians have extended the minimum alveolar concentration (MAC) to deliver and monitor long-term volatile sedation in critically ill patients. There is limited evidence of MAC’s reliability in controlling sedation depth in this setting. We hypothesized that se...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgevici, Adrian-Iustin, Kyprianou, Theodoros, Herzog-Niescery, Jennifer, Procopiuc, Livia, Loganathan, Sivakkanan, Weber, Thomas Peter, Bellgardt, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042630/
https://www.ncbi.nlm.nih.gov/pubmed/33849618
http://dx.doi.org/10.1186/s13054-021-03556-y
_version_ 1783678158562656256
author Georgevici, Adrian-Iustin
Kyprianou, Theodoros
Herzog-Niescery, Jennifer
Procopiuc, Livia
Loganathan, Sivakkanan
Weber, Thomas Peter
Bellgardt, Martin
author_facet Georgevici, Adrian-Iustin
Kyprianou, Theodoros
Herzog-Niescery, Jennifer
Procopiuc, Livia
Loganathan, Sivakkanan
Weber, Thomas Peter
Bellgardt, Martin
author_sort Georgevici, Adrian-Iustin
collection PubMed
description BACKGROUND: Intensive care unit (ICU) physicians have extended the minimum alveolar concentration (MAC) to deliver and monitor long-term volatile sedation in critically ill patients. There is limited evidence of MAC’s reliability in controlling sedation depth in this setting. We hypothesized that sedation depth, measured by the electroencephalography (EEG)-derived Narcotrend-Index (burst-suppression N_Index 0—awake N_Index 100), might drift downward over time despite constant MAC values. METHODS: This prospective single-centre randomized clinical study was conducted at a University Hospital Surgical Intensive Care Unit and included consecutive, postoperative ICU patients fulfilling the inclusion criteria. Patients were randomly assigned to receive uninterrupted inhalational sedation with isoflurane, sevoflurane, or desflurane. The end-expiratory concentration of the anaesthetics and the EEG-derived index were measured continuously in time-stamped pairs. Sedation depth was also monitored using Richmond-Agitation-Sedation-Scale (RASS). The paired t-test and linear models (bootstrapped or multilevel) have been employed to analyze MAC, N_Index and RASS across the three groups. RESULTS: Thirty patients were recruited (female/male: 10/20, age 64 ± 11, Simplified Acute Physiology Score II 30 ± 10). In the first 24 h, 21.208 pairs of data points (N_Index and MAC) were recorded. The median MAC of 0.58 ± 0.06 remained stable over the sedation time in all three groups. The t-test indicated in the isoflurane and sevoflurane groups a significant drop in RASS and EEG-derived N_Index in the first versus last two sedation hours. We applied a multilevel linear model on the entire longitudinal data, nested per patient, which produced the formula N_Index = 43 − 0.7·h (R(2) = 0.76), showing a strong negative correlation between sedation’s duration and the N_Index. Bootstrapped linear models applied for each sedation group produced: N_Index of 43–0.9, 45–0.8, and 43–0.4·h for isoflurane, sevoflurane, and desflurane, respectively. The regression coefficient for desflurane was almost half of those for isoflurane and sevoflurane, indicating a less pronounced time-effect in this group. CONCLUSIONS: Maintaining constant MAC does not guarantee stable sedation depth. Thus, the patients necessitate frequent clinical assessments or, when unfeasible, continuous EEG monitoring. The differences across different volatile anaesthetics regarding their time-dependent negative drift requires further exploration. Trial registration: NCT03860129. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03556-y.
format Online
Article
Text
id pubmed-8042630
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80426302021-04-13 Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial Georgevici, Adrian-Iustin Kyprianou, Theodoros Herzog-Niescery, Jennifer Procopiuc, Livia Loganathan, Sivakkanan Weber, Thomas Peter Bellgardt, Martin Crit Care Research BACKGROUND: Intensive care unit (ICU) physicians have extended the minimum alveolar concentration (MAC) to deliver and monitor long-term volatile sedation in critically ill patients. There is limited evidence of MAC’s reliability in controlling sedation depth in this setting. We hypothesized that sedation depth, measured by the electroencephalography (EEG)-derived Narcotrend-Index (burst-suppression N_Index 0—awake N_Index 100), might drift downward over time despite constant MAC values. METHODS: This prospective single-centre randomized clinical study was conducted at a University Hospital Surgical Intensive Care Unit and included consecutive, postoperative ICU patients fulfilling the inclusion criteria. Patients were randomly assigned to receive uninterrupted inhalational sedation with isoflurane, sevoflurane, or desflurane. The end-expiratory concentration of the anaesthetics and the EEG-derived index were measured continuously in time-stamped pairs. Sedation depth was also monitored using Richmond-Agitation-Sedation-Scale (RASS). The paired t-test and linear models (bootstrapped or multilevel) have been employed to analyze MAC, N_Index and RASS across the three groups. RESULTS: Thirty patients were recruited (female/male: 10/20, age 64 ± 11, Simplified Acute Physiology Score II 30 ± 10). In the first 24 h, 21.208 pairs of data points (N_Index and MAC) were recorded. The median MAC of 0.58 ± 0.06 remained stable over the sedation time in all three groups. The t-test indicated in the isoflurane and sevoflurane groups a significant drop in RASS and EEG-derived N_Index in the first versus last two sedation hours. We applied a multilevel linear model on the entire longitudinal data, nested per patient, which produced the formula N_Index = 43 − 0.7·h (R(2) = 0.76), showing a strong negative correlation between sedation’s duration and the N_Index. Bootstrapped linear models applied for each sedation group produced: N_Index of 43–0.9, 45–0.8, and 43–0.4·h for isoflurane, sevoflurane, and desflurane, respectively. The regression coefficient for desflurane was almost half of those for isoflurane and sevoflurane, indicating a less pronounced time-effect in this group. CONCLUSIONS: Maintaining constant MAC does not guarantee stable sedation depth. Thus, the patients necessitate frequent clinical assessments or, when unfeasible, continuous EEG monitoring. The differences across different volatile anaesthetics regarding their time-dependent negative drift requires further exploration. Trial registration: NCT03860129. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03556-y. BioMed Central 2021-04-13 /pmc/articles/PMC8042630/ /pubmed/33849618 http://dx.doi.org/10.1186/s13054-021-03556-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Georgevici, Adrian-Iustin
Kyprianou, Theodoros
Herzog-Niescery, Jennifer
Procopiuc, Livia
Loganathan, Sivakkanan
Weber, Thomas Peter
Bellgardt, Martin
Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title_full Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title_fullStr Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title_full_unstemmed Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title_short Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
title_sort negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042630/
https://www.ncbi.nlm.nih.gov/pubmed/33849618
http://dx.doi.org/10.1186/s13054-021-03556-y
work_keys_str_mv AT georgeviciadrianiustin negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT kyprianoutheodoros negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT herzogniesceryjennifer negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT procopiuclivia negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT loganathansivakkanan negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT weberthomaspeter negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial
AT bellgardtmartin negativedriftofsedationdepthincriticallyillpatientsreceivingconstantminimumalveolarconcentrationofisofluranesevofluraneordesfluranearandomizedcontrolledtrial